687 related articles for article (PubMed ID: 24590287)
21. Soluble RARRES1 induces podocyte apoptosis to promote glomerular disease progression.
Chen A; Feng Y; Lai H; Ju W; Li Z; Li Y; Wang A; Hong Q; Zhong F; Wei C; Fu J; Guan T; Liu B; Kretzler M; Lee K; He JC
J Clin Invest; 2020 Oct; 130(10):5523-5535. PubMed ID: 32634130
[TBL] [Abstract][Full Text] [Related]
22. The long noncoding RNA LOC105374325 causes podocyte injury in individuals with focal segmental glomerulosclerosis.
Hu S; Han R; Shi J; Zhu X; Qin W; Zeng C; Bao H; Liu Z
J Biol Chem; 2018 Dec; 293(52):20227-20239. PubMed ID: 30389788
[TBL] [Abstract][Full Text] [Related]
23. Renal Glomerular Expression of WT-1, TGF-β, VEGF, and ET-1 Immunostains in Murine Models of Focal and Segmental Glomerulosclerosis.
Husain S
Appl Immunohistochem Mol Morphol; 2023 Sep; 31(8):574-582. PubMed ID: 37615656
[TBL] [Abstract][Full Text] [Related]
24. Aberrant Notch1-dependent effects on glomerular parietal epithelial cells promotes collapsing focal segmental glomerulosclerosis with progressive podocyte loss.
Ueno T; Kobayashi N; Nakayama M; Takashima Y; Ohse T; Pastan I; Pippin JW; Shankland SJ; Uesugi N; Matsusaka T; Nagata M
Kidney Int; 2013 Jun; 83(6):1065-75. PubMed ID: 23447065
[TBL] [Abstract][Full Text] [Related]
25. Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis.
Suzuki T; Matsusaka T; Nakayama M; Asano T; Watanabe T; Ichikawa I; Nagata M
Am J Pathol; 2009 May; 174(5):1675-82. PubMed ID: 19359523
[TBL] [Abstract][Full Text] [Related]
26. Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis.
Kim JH; Kim BK; Moon KC; Hong HK; Lee HS
Kidney Int; 2003 Nov; 64(5):1715-21. PubMed ID: 14531804
[TBL] [Abstract][Full Text] [Related]
27. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
[TBL] [Abstract][Full Text] [Related]
28. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
[TBL] [Abstract][Full Text] [Related]
29. Baicalin alleviates adriamycin-induced focal segmental glomerulosclerosis and proteinuria by inhibiting the Notch1-Snail axis mediated podocyte EMT.
Dou Y; Shang Y; Shen Y; Qu J; Liu C; Cao J
Life Sci; 2020 Sep; 257():118010. PubMed ID: 32598932
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of Scarring in Focal Segmental Glomerulosclerosis.
Zhong J; Whitman JB; Yang HC; Fogo AB
J Histochem Cytochem; 2019 Sep; 67(9):623-632. PubMed ID: 31116068
[TBL] [Abstract][Full Text] [Related]
31. HIV-associated nephropathy: experimental models.
Avila-Casado C; Fortoul TI; Chugh SS
Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
[TBL] [Abstract][Full Text] [Related]
32. Bradykinin receptor 1 activation exacerbates experimental focal and segmental glomerulosclerosis.
Pereira RL; Buscariollo BN; Corrêa-Costa M; Semedo P; Oliveira CD; Reis VO; Maquigussa E; Araújo RC; Braga TT; Soares MF; Moura IC; Malheiros DM; Filho AP; Keller AC; Câmara NO
Kidney Int; 2011 Jun; 79(11):1217-27. PubMed ID: 21412216
[TBL] [Abstract][Full Text] [Related]
33. Pathogenic role of TGF-β in the progression of podocyte diseases.
Lee HS
Histol Histopathol; 2011 Jan; 26(1):107-16. PubMed ID: 21117032
[TBL] [Abstract][Full Text] [Related]
34. Pathobiology of focal segmental glomerulosclerosis: new developments.
D'Agati VD
Curr Opin Nephrol Hypertens; 2012 May; 21(3):243-50. PubMed ID: 22357339
[TBL] [Abstract][Full Text] [Related]
35. Mpv17 in mitochondria protects podocytes against mitochondrial dysfunction and apoptosis in vivo and in vitro.
Casalena G; Krick S; Daehn I; Yu L; Ju W; Shi S; Tsai SY; D'Agati V; Lindenmeyer M; Cohen CD; Schlondorff D; Bottinger EP
Am J Physiol Renal Physiol; 2014 Jun; 306(11):F1372-80. PubMed ID: 24598802
[TBL] [Abstract][Full Text] [Related]
36. Deletion of podocyte Rho-associated, coiled-coil-containing protein kinase 2 protects mice from focal segmental glomerulosclerosis.
Matoba K; Nagai Y; Sekiguchi K; Ohashi S; Mitsuyoshi E; Shimoda M; Tachibana T; Kawanami D; Yokota T; Utsunomiya K; Nishimura R
Commun Biol; 2024 Apr; 7(1):402. PubMed ID: 38565675
[TBL] [Abstract][Full Text] [Related]
37. CLEC14A protects against podocyte injury in mice with adriamycin nephropathy.
Su Z; Li Y; Lv H; Cui X; Liu M; Wang Z; Zhang Y; Zhen J; Tang W; Wang X; Yi F
FASEB J; 2021 Jul; 35(7):e21711. PubMed ID: 34107098
[TBL] [Abstract][Full Text] [Related]
38. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II type-2-receptor stimulation ameliorates focal and segmental glomerulosclerosis in mice.
Liao MC; Miyata KN; Chang SY; Zhao XP; Lo CS; El-Mortada MA; Peng J; Chenier I; Yamashita M; Ingelfinger JR; Chan JSD; Zhang SL
Clin Sci (Lond); 2022 May; 136(10):715-731. PubMed ID: 35502764
[TBL] [Abstract][Full Text] [Related]
40. Endothelial Endothelin Receptor A Expression Is Associated With Podocyte Injury and Oxidative Stress in Patients With Focal Segmental Glomerulosclerosis.
van de Lest NA; Bakker AE; Dijkstra KL; Zandbergen M; Heemskerk SAC; Wolterbeek R; Bruijn JA; Scharpfenecker M
Kidney Int Rep; 2021 Jul; 6(7):1939-1948. PubMed ID: 34307988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
